--2026/FY-- / 4.649M--
--2025/FY-- / 0.000--
--2024/FY0.000 / 0.000--
--2021/FY0.000 / 0.000--
--------
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
MasterCard
MA
CA Stock MarketDetailed Quotes
XRTX XORTX Therapeutics Inc
- 1.430
- +0.030+2.14%
15min DelayMarket Closed May 6 16:00 ET
5.42MMarket Cap-0.86P/E (TTM)
1.440High1.430Low200Volume1.440Open1.400Pre Close287.00Turnover3.94052wk High0.01%Turnover Ratio3.79MShares1.15052wk Low-1.654EPS TTM4.73MFloat Cap44.100Historical HighLossP/E (Static)3.31MShs Float1.150Historical Low-1.654EPS LYR0.71%Amplitude--Dividend TTM1.17P/B1Lot Size--Div YieldTTM
XORTX Therapeutics Inc Key Stats
XORTX Therapeutics Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
XORTX Therapeutics Inc Earnings Reports
Read more
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting